Publication
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS
Tim Spelman, Tomas Kalincik, Vilija Jokubaitis, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Shibeshih Belachew, Robert Hyde, Freek Verheul, Alessandra Lugaresi, Eva Havrdová, Dana Horáková, Pierre Grammond, Pierre Duquette, Alexandre Prat, Gerardo Iuliano, Murat Terzi, Guillermo Izquierdo, Raymond M.M. Hupperts, Cavit Boz, Eugenio Pucci, Giorgio Giuliani, Patrizia Sola, Daniele L.A. Spitaleri, Jeannette Lechner-Scott, Roberto Bergamaschi, François Grand'Maison, Franco Granella, Ludwig Kappos, Maria Trojano
Neurology Clinical Practice, March 2016, Wolters Kluwer Health
DOI: 10.1212/cpj.0000000000000227